Torreggiani Massimo, Piccoli Giorgina Barbara, Moio Maria Rita, Conte Ferruccio, Magagnoli Lorenza, Ciceri Paola, Cozzolino Mario
Néphrologie et Dialyse, Centre Hospitalier Le Mans, 194 Avenue Rubillard, 72037 Le Mans, France.
Renal Division, Department of Health Sciences, Uiniversity of Milan, San Paolo Hospital, 20142 Milan, Italy.
J Clin Med. 2023 May 7;12(9):3328. doi: 10.3390/jcm12093328.
Chronic kidney disease and the need for kidney replacement therapy have increased dramatically in recent decades. Forecasts for the coming years predict an even greater increase, especially in low- and middle-income countries, due to the rise in metabolic and cardiovascular diseases and the aging population. Access to kidney replacement treatments may not be available to all patients, making it especially strategic to set up therapy programs that can ensure the best possible treatment for the greatest number of patients. The choice of the "ideal" kidney replacement therapy often conflicts with medical availability and the patient's tolerance. This paper discusses the pros and cons of various kidney replacement therapy options and their real-world applicability limits.
近几十年来,慢性肾脏病及肾脏替代治疗的需求急剧增加。由于代谢性疾病和心血管疾病的增多以及人口老龄化,未来几年的预测显示这一增长将更为显著,尤其是在低收入和中等收入国家。并非所有患者都能获得肾脏替代治疗,因此建立能够确保为尽可能多的患者提供最佳治疗的治疗项目具有特别重要的战略意义。“理想”的肾脏替代治疗选择往往与医疗可及性和患者耐受性相冲突。本文讨论了各种肾脏替代治疗方案的利弊及其在现实世界中的应用局限性。